|Bid||554.04 x 1200|
|Ask||560.56 x 800|
|Day's Range||552.00 - 560.42|
|52 Week Range||305.63 - 567.81|
|Beta (5Y Monthly)||0.77|
|PE Ratio (TTM)||104.15|
|Earnings Date||Oct 25, 2021 - Oct 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||525.60|
Hot stocks can be found across all industries and sectors, but whether or not these high-flying companies are worth the price of admission is often another story. The following two stocks are absolutely sizzling right now, but they also both boast superior businesses with strong competitive advantages that generate and sustain consistent demand and robust profits. Medical device maker DexCom (NASDAQ: DXCM) may not be a household name for many investors, but it should be.
Expanded access to Dexcom's (DXCM) G6 CGM for clients enrolled in NIHB is expected to aid a wider patient pool to better manage their diabetes.
BURNABY, British Columbia, September 13, 2021--Non-Insured Health Benefits Program now Covers Dexcom G6 CGM System for Children and Adolescents on Intensive Insulin Therapy